Ekso Bionics Holdings
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Ekso Bionics Holdings's past years’ income statements indicate that its last revenue has increased compared to the previous period by 42% to $18,279,000. Profit margin reached -83%. Total operating expenses were $24,191,000.

Profit Margin

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO): Profit margin
2014 5.32M -33.76M -633.92%
2015 8.66M -19.59M -226.19%
2016 14.22M -23.47M -165.04%
2017 7.35M -29.12M -396.06%
2018 11.33M -26.99M -238.19%
2019 13.91M -11.69M -84.03%
2020 8.88M -16.95M -190.88%
2021 11.24M -8.43M -74.98%
2022 12.91M -14.60M -113.1%
2023 18.27M -15.19M -83.14%

EKSO Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
18.27M12.91M11.24M8.88M13.91M11.33M7.35M14.22M8.66M5.32M
Cost of revenue
9.2M6.69M4.49M3.81M7.15M7.02M5.28M11.27M7.48M3.76M
Gross profit
9.07M6.21M6.74M5.07M6.76M4.30M2.06M2.94M1.17M1.55M
Operating exp.
Research and development
5.02M3.62M2.74M2.47M4.59M5.84M9.48M8.87M6.48M3.86M
Selling and marketing
8.47M7.15M7.30M7.75M11.39M13.82M13.15M10.99M9.25M7.08M
Total operating expenses
24.19M21.77M20.57M17.92M23.40M31.37M33.35M30.72M22.74M18.35M
Operating income
-15.11M-15.55M-13.82M-12.85M-16.63M-27.03M-31.61M-27.58M-21.56M-16.79M
Other income (expenses), net
-86K476K4.06M-2.96M4.50M673K2.49M4.48M1.97M-16.97M
Income before tax
-15.19M-15.08M-9.76M-15.82M-12.13M-26.99M-29.12M-23.47M-19.59M-33.76M
Income tax expense
0-476K-1.33M1.12M-438K1.27M944K-6.16M-965K-371K
Net income
-15.19M-14.60M-8.43M-16.95M-11.69M-26.99M-29.12M-23.47M-19.59M-33.76M
Earnings per share
Basic EPS
-1.1-1.13-0.69-2.37-2.44-6.61-12.27-19.42-15.53-34.96
Diluted EPS
-1.1-1.13-0.69-2.37-2.44-6.61-12.27-18.9-15.52-34.96
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source